Human eosinophils express functional interleukin 2 receptors
- PMID: 1885772
- PMCID: PMC295468
- DOI: 10.1172/JCI115383
Human eosinophils express functional interleukin 2 receptors
Abstract
Because T cell-derived cytokines may affect the functioning of eosinophils, we have investigated the capacity of human eosinophils to respond to IL-2. IL-2 was a potent chemoattractant with ED50 of 10(-12) M with eosinophils from all normal and eosinophilic donors tested. The monoclonal antibodies anti-Tac and TU27 against p55 (Tac/CD25) and p75 receptor subunits, respectively, each inhibited IL-2-dependent eosinophil migration. The molar potency of IL-2 and the inhibitory activity of each of the above antibodies suggest that high affinity heterodimeric IL-2 receptor complexes mediated the migration responses of eosinophils to IL-2. Binding of monoclonal antibody against p75 was not detectable by flow cytometry, and high affinity binding sites for 125I-IL-2 were below the limits of quantitation on eosinophils from individuals with eosinophilia. Expression of p55 (Tac/CD25) by eosinophils, without requirement for in vitro activation, was demonstrable by flow cytometry, radioimmunoprecipitation, and Northern blotting for mRNA. Surface expression of p55 on eosinophils from normal or eosinophilic individuals increased during culture for 24-48 h with a biologic activity purified from stimulated U937 cells and to a lesser extent with granulocyte-macrophage CSF or lymphocyte chemoattractant factor but not with nine other cytokines. These studies indicate that blood eosinophils respond to IL-2 and identify one mechanism whereby activation of T lymphocytes may influence the function of eosinophils.
Similar articles
-
Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit.Eur J Immunol. 1991 May;21(5):1265-70. doi: 10.1002/eji.1830210525. Eur J Immunol. 1991. PMID: 2037012
-
Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.J Allergy Clin Immunol. 2001 Jul;108(1):21-8. doi: 10.1067/mai.2001.116864. J Allergy Clin Immunol. 2001. PMID: 11447378
-
The effect of transendothelial migration on eosinophil function.Am J Respir Cell Mol Biol. 2000 Sep;23(3):379-88. doi: 10.1165/ajrcmb.23.3.3707. Am J Respir Cell Mol Biol. 2000. PMID: 10970830
-
[Induction of gene (mRNA) expression of CD23, CD25 and CD4 on eosinophils by eosinophilopoietic growth lymphokines].Nihon Rinsho. 1993 Mar;51(3):581-7. Nihon Rinsho. 1993. PMID: 8492430 Review. Japanese.
-
Cytokine regulation of eosinophil function.Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 2):S55-9. doi: 10.1016/0090-1229(92)90041-l. Clin Immunol Immunopathol. 1992. PMID: 1728988 Review.
Cited by
-
Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB study.Cancer Immunol Immunother. 1993 Oct;37(5):307-15. doi: 10.1007/BF01518453. Cancer Immunol Immunother. 1993. PMID: 8402734 Free PMC article. Clinical Trial.
-
Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity.Front Immunol. 2014 Nov 10;5:570. doi: 10.3389/fimmu.2014.00570. eCollection 2014. Front Immunol. 2014. PMID: 25426119 Free PMC article. Review.
-
Immunity and Breast Cancer: Focus on Eosinophils.Biomedicines. 2021 Aug 26;9(9):1087. doi: 10.3390/biomedicines9091087. Biomedicines. 2021. PMID: 34572273 Free PMC article. Review.
-
On the role of sIL-2R measurements in rheumatoid arthritis and cancers.Mediators Inflamm. 2005 Aug 14;2005(3):121-30. doi: 10.1155/MI.2005.121. Mediators Inflamm. 2005. PMID: 16106097 Free PMC article. Review.
-
A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.J Exp Med. 2013 Dec 16;210(13):2939-50. doi: 10.1084/jem.20130351. Epub 2013 Dec 9. J Exp Med. 2013. PMID: 24323357 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials